Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
JMIR Formative Research
|
February 18, 2021
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
Alberto Mussetti, Maria Queralt Salas, Maria Condom, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2026
Assessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomes
Annalisa Paviglianiti, Marta Bellver Sanchis, Marta Peña, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen
Anna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Kidney Medicine
|
August 17, 2021
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient
Edoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, et al.
Transplantation and Cellular Therapy
|
November 14, 2025
EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study
Marta Peña, Diego Fernando Martinez, Lucía López-Corral, et al.
Leukemia & Lymphoma
|
April 16, 2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide
Vittorio Montefusco, Monica Galli, Francesco Spina, et al.
Leukemia & Lymphoma
|
February 5, 2015
Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon
Pellegrino Musto, Vincenzo Ludovico Fraticelli, Giovanna Mansueto, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Scientific Reports
|
June 22, 2026
Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay
Silvia Torrents, Ana García-Buendía, Margarita Codinach, et al.
Bone Marrow Transplantation
|
August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT
Ivan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
JMIR Formative Research
|
February 18, 2021
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
Alberto Mussetti, Maria Queralt Salas, Maria Condom, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2026
Assessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomes
Annalisa Paviglianiti, Marta Bellver Sanchis, Marta Peña, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen
Anna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Kidney Medicine
|
August 17, 2021
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient
Edoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, et al.
Transplantation and Cellular Therapy
|
November 14, 2025
EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study
Marta Peña, Diego Fernando Martinez, Lucía López-Corral, et al.
Leukemia & Lymphoma
|
April 16, 2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide
Vittorio Montefusco, Monica Galli, Francesco Spina, et al.
Leukemia & Lymphoma
|
February 5, 2015
Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon
Pellegrino Musto, Vincenzo Ludovico Fraticelli, Giovanna Mansueto, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Scientific Reports
|
June 22, 2026
Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay
Silvia Torrents, Ana García-Buendía, Margarita Codinach, et al.
Bone Marrow Transplantation
|
August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT
Ivan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
Page
of 10